Oral and intra-articular remedies: Review of papers published from March 2001 to February 2002

Research output: Contribution to journalArticle

Standard

Oral and intra-articular remedies: Review of papers published from March 2001 to February 2002. / Jubb, Ronald.

In: Current Opinion in Rheumatology, Vol. 14, 01.01.2002, p. 597-602.

Research output: Contribution to journalArticle

Harvard

APA

Vancouver

Author

Bibtex

@article{b03b48fd2c3c4aa691faddae51d6f048,
title = "Oral and intra-articular remedies: Review of papers published from March 2001 to February 2002",
abstract = "There have been considerable advances in the drug treatments used to treat osteoarthritis. The development of selective cyclo-oxygenase inhibitors (COX-II) and confirmation of their efficacy and gastrointestinal safety will reduce treatment morbidity in the elderly. Guidelines for safe and appropriate use of COX-II drugs are now available. The role of anti-inflammatory drugs in precipitating cardiorenal events has been highlighted but remains to be fully evaluated. Glucosamine, diacerein, and hyaluronan may all be disease-modifying drugs for osteoarthritis but confirmatory studies are still needed.",
author = "Ronald Jubb",
year = "2002",
month = jan,
day = "1",
doi = "10.1097/00002281-200209000-00021",
language = "English",
volume = "14",
pages = "597--602",
journal = "Current Opinion in Rheumatology",
issn = "1040-8711",
publisher = "Lippincott Williams and Wilkins",

}

RIS

TY - JOUR

T1 - Oral and intra-articular remedies: Review of papers published from March 2001 to February 2002

AU - Jubb, Ronald

PY - 2002/1/1

Y1 - 2002/1/1

N2 - There have been considerable advances in the drug treatments used to treat osteoarthritis. The development of selective cyclo-oxygenase inhibitors (COX-II) and confirmation of their efficacy and gastrointestinal safety will reduce treatment morbidity in the elderly. Guidelines for safe and appropriate use of COX-II drugs are now available. The role of anti-inflammatory drugs in precipitating cardiorenal events has been highlighted but remains to be fully evaluated. Glucosamine, diacerein, and hyaluronan may all be disease-modifying drugs for osteoarthritis but confirmatory studies are still needed.

AB - There have been considerable advances in the drug treatments used to treat osteoarthritis. The development of selective cyclo-oxygenase inhibitors (COX-II) and confirmation of their efficacy and gastrointestinal safety will reduce treatment morbidity in the elderly. Guidelines for safe and appropriate use of COX-II drugs are now available. The role of anti-inflammatory drugs in precipitating cardiorenal events has been highlighted but remains to be fully evaluated. Glucosamine, diacerein, and hyaluronan may all be disease-modifying drugs for osteoarthritis but confirmatory studies are still needed.

UR - http://www.scopus.com/inward/record.url?scp=0036707744&partnerID=8YFLogxK

U2 - 10.1097/00002281-200209000-00021

DO - 10.1097/00002281-200209000-00021

M3 - Article

C2 - 12192262

VL - 14

SP - 597

EP - 602

JO - Current Opinion in Rheumatology

JF - Current Opinion in Rheumatology

SN - 1040-8711

ER -